Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study.
Saved in:
| Title: | Immunogenicity and Safety of Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Potential Hajj/Umrah Pilgrims Aged ≥ 56 Years: A Phase III, Open-Label Study. |
|---|---|
| Authors: | Dbaibo, Ghassan S.1,2 (AUTHOR), Balik, Ismail3 (AUTHOR), Akdemir, İrem3 (AUTHOR), Buzgan, Turan4 (AUTHOR), Guner, Rahmet4 (AUTHOR), Boutros, Celina F.1 (AUTHOR), Damaj, Stephanie1 (AUTHOR), Zein, Zeinab El1,2 (AUTHOR), Merhi, Sarah1 (AUTHOR), Faour, Kawthar5 (AUTHOR), Tfaily, Nadim1 (AUTHOR), Khafaja, Sarah1,2 (AUTHOR), Dogu, Alp6 (AUTHOR) Alp.Dogu@sanofi.com, Ceyhan, Mehmet7 (AUTHOR) |
| Source: | Infectious Diseases & Therapy. Mar2026, Vol. 15 Issue 3, p769-785. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
